ABSTRACT
Background Coronaviruses such as SARS-CoV-2 may circumvent host defence mechanisms by hijacking host proteins, possibly by altering DNA methylation patterns in host cells. While most epigenetic studies have been performed in severely ill COVID-19 patients, studies on individuals who have recovered from mild-to-moderate disease remain scarce. The aim of this study was to assess epigenome-wide DNA methylation patterns in COVID-19 convalescents compared to uninfected controls from before and after the pandemic outbreak began.
Methods DNA was extracted from peripheral blood mononuclear cells originating from uninfected controls before (Pre20, n=5) and after (Con, n=18) 2020, COVID-19 convalescents (CC19, n=14) and symptom-free individuals with a SARS-CoV-2-specific T cell response (SFT, n=6), as well as from Pre20 (n=4) samples stimulated in vitro with SARS-CoV-2. Subsequently, epigenome-wide DNA methylation analyses were performed using the Illumina MethylationEPIC 850K array, and statistical and bioinformatic analyses comprised differential DNA methylation, pathway over-representation and module identification network analyses.
Results DNA methylation patterns of COVID-19 convalescents were altered as compared to uninfected controls, with similar results observed in in vitro stimulations of PBMC with SARS-CoV-2. Differentially methylated genes from the in vivo comparison constituted the foundation for the identification of a possibly SARS-CoV-2-induced module, containing 66 genes of which six could also be identified in corresponding analyses of the in vitro data (TP53, INS, HSPA4, SP1, ESR1 and FAS). Pathway over-representation analyses revealed involvement of Wnt, cadherin and apoptosis signalling pathways amongst others. Furthermore, numerous interactions were found between the obtained differentially methylated genes from both settings and the network analyses when overlaying the data unto the SARS-CoV-2 interactome.
Conclusions Epigenome-wide DNA methylation patxterns of individuals that have recovered from mild-to-moderate COVID-19 are different from those of non-infected controls. The observed alterations during both in vivo and in vitro exposure to SARS-CoV-2 showed involvement in interactions and pathways that are highly relevant to COVID-19. The present study provides indications that DNA methylation is one of several epigenetic mechanisms that is altered upon SARS-CoV-2 infection. Further studies on the mechanistic underpinnings should determine whether the observed effects are reflecting host-protective antiviral defence or targeted viral hijacking to evade host defence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by grants from the Swedish Heart and Lung Foundation (M.L.: 20200319), the Swedish Research Council (A.R.: Covid-19/biobank 210202#1) and the Open Medicine foundation (A.R.: OMF190626).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Regional Ethics Committee for Human Research in Linkoeping (Dnr. 2019-0618)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Shared first authorship
Data Availability
The datasets used and/or analysed in the presented work will be available upon publication due to a pending patent, for reference: GeneExpression Omnibus (GEO-ID: GSE178962).
LIST OF ABBREVIATIONS
- CC19
- convalescent COVID-19 individuals
- Con
- Control (uninfected pandemic)
- COVID-19
- Coronavirus disease -19
- DMC
- differentially methylated CpG site
- DMG
- differentially methylated gene
- DNAm
- DNA methylation
- MMD
- mean methylation difference
- PBMC
- peripheral blood mononuclear cell
- PC
- principal component
- PCA
- principal component analysis
- PPI
- protein-protein interaction
- Pre20
- Control (uninfected, pre-pandemic 2020)
- SARS
- severe acute respiratory syndrome
- SARS-CoV-2
- severe acute respiratory syndrome corona virus 2
- SFT
- symptom-free individuals with T cell response
- SMIA
- suspension multiplex immunoassay